[1]
“Evaluation of the anti-inflammatory activity and ulcerogenic liability of 5-(3-chloro-1-benzothien -2-yl)-4-phenyl-4H-1,2,4-triazole-3-thiol”, AJPHS, vol. 2, no. 4, pp. 535–538, Dec. 2012, doi: 10.5530/nyp80b28.